GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹10,611 Cr | ₹8,778 Cr | ₹7,834 Cr | ₹6,496 Cr | ₹4,086 Cr |
What is the latest Total Liabilities ratio of GLAND PHARMA ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹10,611 Cr |
Mar2023 | ₹8,778 Cr |
Mar2022 | ₹7,834 Cr |
Mar2021 | ₹6,496 Cr |
Mar2020 | ₹4,086 Cr |
How is Total Liabilities of GLAND PHARMA Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹10,611 Cr | 20.89 | |
Mar2023 | ₹8,778 Cr | 12.05 | |
Mar2022 | ₹7,834 Cr | 20.59 | |
Mar2021 | ₹6,496 Cr | 58.98 | |
Mar2020 | ₹4,086 Cr | - |
Compare Total Liabilities of peers of GLAND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAND PHARMA | ₹31,247.7 Cr | 1% | 7.2% | -7.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
GLAND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAND PHARMA | 1% |
7.2% |
-7.9% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses